Lysine methyltransferase methyltransferase-like 13 regulates bone marrow mesenchymal stem cells osteo-adipogenic differentiation and senescence in osteoporosis via the Foxa1/HES-1 axis
Stem Cells Translational Medicine · 20.07.2026 · 15 (8)
DOI: 10.1093/stcltm/szag049 ↗Kurz gefasst
Fachartikel in der Zeitschrift Stem Cells Translational Medicine, online erschienen am 28.07.2026. Verfasst von Ying Liu und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology (State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD), State-Province Key Laboratories of Biomedicine Pha…. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Cellular Senescence, Osteoporosis, Adipogenesis. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China.
Abstract (Originalsprache)
Purpose
Recent research indicates that the senescence of bone marrow mesenchymal stem cells (BMSCs) disrupts the osteo-adipogenic balance, a primary factor contributing to the development of osteoporosis. Our previous findings have implicated methyltransferases in this process, among which methyltransferase-like 13 (METTL13) has been established to regulate cell fate, although its role in osteoporosis has yet to be determined.
Methods
Bone formation was assessed using micro-computed tomography and hematoxylin and eosin staining. Protein expression in bone tissues was examined immunohistochemically, and cellular mRNA and protein levels were determined using quantitative reverse transcription-polymerase chain reaction (qRT-PCR) and western blotting. Cellular senescence was evaluated based on β-galactosidase staining, and osteogenic and adipogenic differentiation was examined using alkaline phosphatase, Alizarin Red S, and Oil Red O staining. Protein interactions and DNA binding were determined using co-immunoprecipitation and chromatin immunoprecipitation.
Results
METTL13 expression was significantly enhanced in ovariectomy-induced senescent bone and BMSCs, whereas METTL13 knockdown markedly reversed etoposide-induced cellular senescence. By binding to forkhead box protein A1 (Foxa1), METTL13 promotes the preferential differentiation of BMSCs into adipocytes, as opposed to osteocytes. Moreover, Foxa1 had effects opposite to those of METTL13 on BMSC differentiation, inhibiting the nuclear entry of METTL13. Notably, blocking the nuclear import of Foxa1 suppressed the transcriptional expression of HES-1, which promoted the adipogenic differentiation of BMSCs and inhibited osteogenic differentiation.
Conclusions
Our findings in this study revealed the mechanisms whereby METTL13 promotes BMSC senescence and disrupts BMSC differentiation, on the basis of which, we identified the METTL13–Foxa1–HES-1 axis as a potential therapeutic target for treatment of osteoporosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology (State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD), State-Province Key Laboratories of Biomedicine Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Minist…
- Department of Orthopedic Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin 150081, China.
- Department of Pharmacy at the Second Affiliated Hospital, State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD), Harbin Medical University, Harbin 150081, China.
- Department of Clinical Pharmacology, College of Pharmacy, Harbin Medical University, Harbin 150081, China.
- Department of Orthopedics at the First Affiliated Hospital, State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD), Harbin Medical University, Harbin 150081, China.
- Center for Endemic Disease Control, Chinese Center for Disease Control and Prevention, Harbin Medical University, Harbin 150081, China.
ORCID-Profile: Shuixing Zhang, Ye Yuan
Förderung
- National Key Research and Development Program of China
Zitieren
APA
Liu, Y., Wang, A., Liu, Z., Qin, Z., Yin, L., Wang, X., He, M., Li, T., Wang, Y., Chen, L., Liu, Z., Liu, J., Gu, B., Yang, S., Liang, H., Li, Y., Zheng, X., Zhang, S., Yang, B., …, & Yang, L. (2026). Lysine methyltransferase methyltransferase-like 13 regulates bone marrow mesenchymal stem cells osteo-adipogenic differentiation and senescence in osteoporosis via the Foxa1/HES-1 axis. Stem Cells Translational Medicine, 15(8). https://doi.org/10.1093/stcltm/szag049
Vancouver
Liu Y, Wang A, Liu Z, Qin Z, Yin L, Wang X, et al. Lysine methyltransferase methyltransferase-like 13 regulates bone marrow mesenchymal stem cells osteo-adipogenic differentiation and senescence in osteoporosis via the Foxa1/HES-1 axis. Stem Cells Translational Medicine. 2026;15(8). doi:10.1093/stcltm/szag049
BibTeX
@article{Liu2026,
author = {Liu, Ying and Wang, Ao and Liu, Ziwen and Qin, Zhengwei and Yin, Lei and Wang, Xinyue and He, Mingyu and Li, Tao and Wang, Yanquan and Chen, Longhao and Liu, Zhuo and Liu, Jiayi and Gu, Binsha and Yang, Shichao and Liang, Hui and Li, Yang and Zheng, Xiaofei and Zhang, Shuixing and Yang, Baofeng and Yuan, Ye and Yang, Lei},
title = {Lysine methyltransferase methyltransferase-like 13 regulates bone marrow mesenchymal stem cells osteo-adipogenic differentiation and senescence in osteoporosis via the Foxa1/HES-1 axis},
journal = {Stem Cells Translational Medicine},
year = {2026},
volume = {15},
number = {8},
doi = {10.1093/stcltm/szag049}
}
EUVIMED